Search

everythinglearnresearchcommunity

for

Search:↓

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Consider benefits and risks of new alopecia treatments for safety.

Finasteride may increase depression by reducing brain cell growth.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

Some medications for bladder problems can cause memory issues or mood changes, and doctors should monitor these side effects.

Combination therapy, especially with finasteride, is effective for treating frontal fibrosing alopecia.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Family doctors can manage older men with urinary symptoms using exams, tests, and medications.

Caffeine can boost health but may cause side effects like high blood pressure and migraines.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Animal models are crucial for learning about hair loss and finding treatments.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

Women with female-pattern baldness produce more testosterone, but 5a-reductase inhibition treatment won't help.

Hirsutism in females is caused by high male hormones or sensitive hair follicles.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

5ARIs like finasteride can help prevent prostate cancer and treat BPH, but guidelines should be updated to reflect this.

Men with male-pattern baldness have higher levels of certain testosterone metabolites and may have more active androgen metabolism.

Young and adult hamsters both respond similarly to testosterone and finasteride treatments, but young hamsters aren't good for testing the inhibitory activity of a specific enzyme.

Low-dose oral minoxidil effectively reduces hair loss in women with female pattern hair loss.

Dutasteride caused more penile tissue changes than finasteride, possibly increasing erectile dysfunction risk.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

Inflammation around hair follicles leads to hair loss, and treatments should focus on reducing this inflammation and other factors for effectiveness.

Testosterone affects stress hormone levels differently in adolescent and adult male rats.

Finasteride treatment in male rats can reduce fertility and affect sperm development in their offspring.